Brain scans could reveal how well hearing aids work in infants
NCT ID NCT04696835
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study explores whether a brain-scanning technique called fNIRS can measure how well hearing aids help young children with hearing loss. Researchers will compare brain activity in 40 infants (3-18 months old) with normal hearing and those using hearing aids. If fNIRS proves reliable, it could offer a better way to fit hearing aids in children who cannot yet respond to standard hearing tests.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
functional near-infrared spectroscopy (fNIRS) brain scan
What this could lead to
If successful, this could provide a new way to assess hearing aid benefits in very young children who cannot respond to standard hearing tests.
What could go wrong
This is a small pilot study with only 40 children, so results may not apply broadly. The technique is still experimental and may not reliably measure brain activity in all cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEARING LOSS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hopital Roger Salengro, CHU Lille
RECRUITINGLille, 59037, France
Contact Phone: •••-•••-••••